Prediction of tumor doubling time in recurrent meningiomas

Cell kinetics studies with bromodeoxyuridine labeling

Restricted access

✓ Eight patients with recurrent meningiomas (four malignant, two hemangiopericytic, and two nonmalignant) were given intravenous bromodeoxyuridine (BUdR), 200 mg/sq m, at the time of surgery to label cells in the deoxyribonucleic acid (DNA) synthesis phase; labeled cells were detected in excised tumor specimens by immunoperoxidase staining using anti-BUdR monoclonal antibody. These tumors showed a wide range of BUdR labeling indices (LI's), calculated as the percentage of BUdR-labeled cells divided by the total number of cells scored, from 0.3% to 5.4%. The tumor doubling times (Td's), estimated from serial computerized tomography scans, ranged from 8 to 440 days and showed a close inverse correlation with the BUdR LI's. A semilogarithmic linear regression analysis of these values yielded a correlation coefficient of 0.99. Tumor doubling time (Td) can be estimated using the formula: Td = 500 × Exp (−0.73 × LI), where Exp signifies the natural log base. By predicting the growth rate of meningiomas, the BUdR LI may supplement histopathological diagnosis and improve both the determination of prognosis and the design of treatment modalities in individual patients.

Article Information

Address reprint requests to: Takao Hoshino, M.D., c/o The Editorial Office, Department of Neurological Surgery, 1360 Ninth Avenue, Suite 210, San Francisco, California 94122.

© AANS, except where prohibited by US copyright law.

Headings

Figures

  • View in gallery

    Tumor doubling time estimated from serial computerized tomography scans is plotted against bromodeoxyuridine (BUdR) labeling index (LI) for each of the eight tumors. Error bars indicate 1 standard deviation, showing the amount of LI variability from area to area within the same tumor.

References

  • 1.

    Adegbite ABKhan MIPaine KWEet al: The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 58:51561983Adegbite AB Khan MI Paine KWE et al: The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 58:51–56 1983

  • 2.

    Bagshaw MADoggett RLSSmith KCet al: Intra-arterial 5-bromodeoxyuridine and x-ray therapy. AJR 99:8868941967Bagshaw MA Doggett RLS Smith KC et al: Intra-arterial 5-bromodeoxyuridine and x-ray therapy. AJR 99:886–894 1967

  • 3.

    Benedict WFPorter IHBrown CDet al: Cytogenetic diagnosis of malignancy in recurrent meningioma. Lancet 1:9719731970Benedict WF Porter IH Brown CD et al: Cytogenetic diagnosis of malignancy in recurrent meningioma. Lancet 1:971–973 1970

  • 4.

    Cervos-Navarro JMartins LFLazaro MC: Ultrastructure of malignant meningioma and meningosarcoma. Acta Neurochir 31:2762771975 (Abstract)Cervos-Navarro J Martins LF Lazaro MC: Ultrastructure of malignant meningioma and meningosarcoma. Acta Neurochir 31:276–277 1975 (Abstract)

  • 5.

    Christensen DLaursen HKlinken L: Prediction of recurrence in meningiomas after surgical treatment. A quantitative approach. Acta Neuropathol 61:1301341983Christensen D Laursen H Klinken L: Prediction of recurrence in meningiomas after surgical treatment. A quantitative approach. Acta Neuropathol 61:130–134 1983

  • 6.

    Craig WM: Malignant intracranial endotheliomata. Surg Gynecol Obstet 45:7607681927Craig WM: Malignant intracranial endotheliomata. Surg Gynecol Obstet 45:760–768 1927

  • 7.

    Crompton MRGautier-Smith PC: The prediction of recurrence in meningiomas. J Neurol Neurosurg Psychiatry 33:80871970Crompton MR Gautier-Smith PC: The prediction of recurrence in meningiomas. J Neurol Neurosurg Psychiatry 33:80–87 1970

  • 8.

    Fromm HSchäfer MVitzthum HG: Clinical course of intracranial meningiomas with respect to their histological stage. Acta Neurochir 31:2771975 (Abstract)Fromm H Schäfer M Vitzthum HG: Clinical course of intracranial meningiomas with respect to their histological stage. Acta Neurochir 31:277 1975 (Abstract)

  • 9.

    Goellner JRLaws ER JrSoule EHet al: Hemangiopericytoma of the meninges. Mayo Clinic experience. Am J Clin Pathol 70:3753801978Goellner JR Laws ER Jr Soule EH et al: Hemangiopericytoma of the meninges. Mayo Clinic experience. Am J Clin Pathol 70:375–380 1978

  • 10.

    Goz B: The effects of incorporation of 5-halogenated deoxyuridines into the DNA of eukaryotic cells. Pharmacol Rev 29:2492721978Goz B: The effects of incorporation of 5-halogenated deoxyuridines into the DNA of eukaryotic cells. Pharmacol Rev 29:249–272 1978

  • 11.

    Gratzner HG: Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science 218:4744751982Gratzner HG: Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science 218:474–475 1982

  • 12.

    Henschen F: Tumoren des Zentralnervensystems und seiner Hüllen in Lubarsch OHenke FRössle R (eds): Handbuch der speziellen pathologischen Anatomie und Histologie. Berlin/Göttingen/Heidelberg: Springer-Verlag1955 Vol 13Part 3 pp 4131040 (see pp 482–486)Henschen F: Tumoren des Zentralnervensystems und seiner Hüllen in Lubarsch O Henke F Rössle R (eds): Handbuch der speziellen pathologischen Anatomie und Histologie. Berlin/Göttingen/Heidelberg: Springer-Verlag 1955 Vol 13 Part 3 pp 413–1040 (see pp 482–486)

  • 13.

    Hoshino TKobayashi STownsend JJet al: A cell kinetic study on medulloblastomas. Cancer 55:171117131985Hoshino T Kobayashi S Townsend JJ et al: A cell kinetic study on medulloblastomas. Cancer 55:1711–1713 1985

  • 14.

    Hoshino TNagashima TMurovic JAet al: Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine. Cytometry 6:6276321985Hoshino T Nagashima T Murovic JA et al: Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine. Cytometry 6:627–632 1985

  • 15.

    Hoshino TNagashima TMurovic JAet al: In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling. J Neurosurg 64:4534591986Hoshino T Nagashima T Murovic JA et al: In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling. J Neurosurg 64:453–459 1986

  • 16.

    Hoshino TNagashima TMurovic JAet al: Proliferative potential of human meningiomas of brain: a cell kinetics study with bromodeoxyuridine. Cancer 58 (In press1986)Hoshino T Nagashima T Murovic JA et al: Proliferative potential of human meningiomas of brain: a cell kinetics study with bromodeoxyuridine. Cancer 58 (In press 1986)

  • 17.

    Hoshino TSano K: Radiosensitization of malignant brain tumours with bromouridine (thymidine analogue). Acta Radiol Ther Phys Biol 8:15261969Hoshino T Sano K: Radiosensitization of malignant brain tumours with bromouridine (thymidine analogue). Acta Radiol Ther Phys Biol 8:15–26 1969

  • 18.

    Hoshino TWilson CB: Cell kinetic analyses of human malignant brain tumors (gliomas). Cancer 44:9569621979Hoshino T Wilson CB: Cell kinetic analyses of human malignant brain tumors (gliomas). Cancer 44:956–962 1979

  • 19.

    Jääskeläinen JHaltia MLaasonen Eet al: The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patients. Surg Neurol 24:1651721985Jääskeläinen J Haltia M Laasonen E et al: The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patients. Surg Neurol 24:165–172 1985

  • 20.

    Jellinger KSlowik F: Histological subtypes and prognostic problems in meningiomas. J Neurol 208:2792981975Jellinger K Slowik F: Histological subtypes and prognostic problems in meningiomas. J Neurol 208:279–298 1975

  • 21.

    Kornblith PL: Role of tissue culture in prediction of malignancy. Clin Neurosurg 25:3463761978Kornblith PL: Role of tissue culture in prediction of malignancy. Clin Neurosurg 25:346–376 1978

  • 22.

    Ludwin SKRubinstein LJRussell DS: Papillary meningioma: a malignant variant of meningioma. Cancer 36:136313731975Ludwin SK Rubinstein LJ Russell DS: Papillary meningioma: a malignant variant of meningioma. Cancer 36:1363–1373 1975

  • 23.

    Mitelman FLevan G: Clustering of aberrations to specific chromosomes in human neoplasms. II. A survey of 287 neoplasms. Hereditas 82:1671741976Mitelman F Levan G: Clustering of aberrations to specific chromosomes in human neoplasms. II. A survey of 287 neoplasms. Hereditas 82:167–174 1976

  • 24.

    Nagashima TDeArmond SJMurovic Jet al: Immunocytochemical demonstration of S-phase cells by antibromodeoxyuridine monoclonal antibody in human brain tumor tissues. Acta Neuropathol 67:1551591985Nagashima T DeArmond SJ Murovic J et al: Immunocytochemical demonstration of S-phase cells by antibromodeoxyuridine monoclonal antibody in human brain tumor tissues. Acta Neuropathol 67:155–159 1985

  • 25.

    Nagashima TMurovic JAHoshino Tet al: The proliferative potential of human pituitary tumors in situ. J Neurosurg 64:5885931986Nagashima T Murovic JA Hoshino T et al: The proliferative potential of human pituitary tumors in situ. J Neurosurg 64:588–593 1986

  • 26.

    Pearlman AW: Breast cancer — influence of growth rate on prognosis and treatment evaluation. A study based on mastectomy scar recurrences. Cancer 38:182618331976Pearlman AW: Breast cancer — influence of growth rate on prognosis and treatment evaluation. A study based on mastectomy scar recurrences. Cancer 38:1826–1833 1976

  • 27.

    Peña CE: Meningioma and intracranial hemangiopericytoma. A comparative electron microscopic study. Acta Neuropathol 39:69741977Peña CE: Meningioma and intracranial hemangiopericytoma. A comparative electron microscopic study. Acta Neuropathol 39:69–74 1977

  • 28.

    Pitkethly DTHardman JMKempe LGet al: Angioblastic meningiomas. Clinicopathologic study of 81 cases. J Neurosurg 32:5395441970Pitkethly DT Hardman JM Kempe LG et al: Angioblastic meningiomas. Clinicopathologic study of 81 cases. J Neurosurg 32:539–544 1970

  • 29.

    Quest DO: Meningiomas: an update. Neurosurgery 3:2192251978Quest DO: Meningiomas: an update. Neurosurgery 3:219–225 1978

  • 30.

    Russell DSRubinstein LJ: Pathology of Tumours of the Nervous Systemed 4. Baltimore: Williams & Wilkins1977 pp 65100Russell DS Rubinstein LJ: Pathology of Tumours of the Nervous System ed 4. Baltimore: Williams & Wilkins 1977 pp 65–100

  • 31.

    Sano KHoshino TNagai M: Radiosensitization of brain tumor cells with a thymidine analogue (bromouridine). J Neurosurg 28:5305381968Sano K Hoshino T Nagai M: Radiosensitization of brain tumor cells with a thymidine analogue (bromouridine). J Neurosurg 28:530–538 1968

  • 32.

    Simpson D: The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22391957Simpson D: The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22–39 1957

  • 33.

    Skullerud KLöken AC: The prognosis in meningiomas. Acta Neuropathol 29:3373441974Skullerud K Löken AC: The prognosis in meningiomas. Acta Neuropathol 29:337–344 1974

  • 34.

    Thomas HGDolman CLBerry K: Malignant meningiomas: clinical and pathological features. J Neurosurg 55:9299341981Thomas HG Dolman CL Berry K: Malignant meningiomas: clinical and pathological features. J Neurosurg 55:929–934 1981

  • 35.

    Tytus JSLasersohn JTReifel E: The problem of malignancy in meningiomas. J Neurosurg 27:5515571967Tytus JS Lasersohn JT Reifel E: The problem of malignancy in meningiomas. J Neurosurg 27:551–557 1967

  • 36.

    Yamashita TFujii SFujino Het al: [Volumetry of brain tumors on CT: significance of the volume ratio by serial CT scanning and estimation of the growth rate of malignant gliomas.] Prog Comput Tomogr (Tokyo) 2:6856891980 (Jpn)Yamashita T Fujii S Fujino H et al: [Volumetry of brain tumors on CT: significance of the volume ratio by serial CT scanning and estimation of the growth rate of malignant gliomas.] Prog Comput Tomogr (Tokyo) 2:685–689 1980 (Jpn)

  • 37.

    Yamashita TKuwabara T: Estimation of rate of growth of malignant brain tumors by computed tomography scanning. Surg Neurol 20:4644701983Yamashita T Kuwabara T: Estimation of rate of growth of malignant brain tumors by computed tomography scanning. Surg Neurol 20:464–470 1983

TrendMD

Cited By

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 98 98 13
Full Text Views 244 244 2
PDF Downloads 108 108 0
EPUB Downloads 0 0 0

PubMed

Google Scholar